“Dupilumab Improves Patient-Reported Outcomes As Early As 1 Month Among Adults With Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s506. https://doi.org/10.25251/skin.8.supp.506.